Início › Síndromes Mielodisplásicas › Geórgia
Ensaios clínicos de Síndromes Mielodisplásicas em Geórgia
15 estudos para Síndromes Mielodisplásicas estão buscando participantes em locais em Geórgia.
Cidades em Geórgia
Texto oficial do estudo (Inglês)
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
- Phoebe Putney Memorial Hospital, Albany
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06577441Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
- Emory University Hospital/Winship Cancer Institute, Atlanta
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06484062A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- Emory University, Atlanta
RecrutandoFase 1
Idades de 12 a 78 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT03802695MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Phoebe Putney Memorial Hospital, Albany
- Augusta University Medical Center, Augusta
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05564390Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- Emory Winship Cancer Institute, Atlanta
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT05320198A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Emory University, Atlanta
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT07422480Collection of Tissue Samples for Cancer Research
- Emory University, Atlanta
RecrutandoEstudo observacional
2 Months · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT00900198The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
- Memorial Health University Medical Center, Savannah
RecrutandoFase 1/2
Até 22 anos · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT04726241A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
- Northside Hospital, Atlanta
RecrutandoFase 1Voluntários saudáveis bem-vindos
Idades de 18 a 75 · Todos os sexos · Atualizado em 28 de jul. de 2026 · NCT07020533A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- University of Emory - Winship Cancer Institute, Atlanta
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 30 de abr. de 2026 · NCT04256317Venetoclax Basket Trial for High Risk Hematologic Malignancies
- Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta
RecrutandoFase 1
Idades de 1 a 40 · Todos os sexos · Atualizado em 12 de mar. de 2026 · NCT05292664CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
- Northside Hospital, Atlanta
RecrutandoFase 2Voluntários saudáveis bem-vindos
Idades de 18 a 75 · Todos os sexos · Atualizado em 10 de mar. de 2026 · NCT06059391CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
- Emory University Hospital, Atlanta
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 16 de jan. de 2026 · NCT05143996Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- Emory University, Atlanta
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 23 de dez. de 2025 · NCT04245397SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Atlanta
- Massive Bio SYNERGY-AI site, Savannah
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.